An improved murine model of asthma: Selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen

Thorax

Volumn 53, Issue 10, 1998, Pages 849-856

  Temelkovski, Jason ^a   Hogan, Simon P ^b   Shepherd, Darren P ^a   Foster, Paul S ^b   Kumar, Rakesh K ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Biology and Environment   (Australia)

Author keywords

Asthma; Epithelial abnormalities; Mucosal inflammation; Murine model

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; METHACHOLINE; OVALBUMIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ASTHMA; BRONCHOSPASM; CELL INFILTRATION; FEMALE; HISTOPATHOLOGY; IMMUNOREACTIVITY; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

EID: 0031781163     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.10.849     Document Type: Article

References (52)

1. Toelle BG, Peat JK, Salome CM, et al. Toward a definition of asthma for epidemiology. Am Rev Respir Dis 1992;146:633-7.
2. Beasley R, Roche WR, Roberts JA, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
3. Kay AB. Pathology of mild, severe and fatal asthma. Am J Respir Crit Care Med 1996;154:S66-9.
4. Hegele RG, Hogg C. The pathology of asthma: an inflammatory disorder. In: Szefler SJ, Leung DYM, eds. Severe asthma: pathogenesis and clinical management. New York: Marcel Dekker, 1996: 61-76.
5. Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996;154:1505-10.
6. Jeffery PK. Pathology of asthma. Br Med Bull 1992;48:23-39.
7. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
8. Ebina M, Takahashi T, Chiba T, et al. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D morphometric study. Am Rev Respir Dis 1993;148:720-6.
9. McFadden ER, Gilbert IA, Asthma. N Engl J Med 1992;327:1928-37.
10. James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989;139:242-6.
11. Ackerman V, Marini M, Vittori E, et al. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994;105:687-96.
12. Tang C, Rolland JM, Ward C, et al. Seasonal comparison of cytokine profiles in atopic asthmatics and atopic non-asthmatics. Am J Respir Crit Care Med 1996;154:1615-22.
13. Wardlaw AJ, Dunnette S, Gleich GJ, et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988;137:62-9.
14. Jeffery PK, Wardlaw AJ, Nelson FC, et al. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140: 1745-53.
15. Davies RJ, Devalia JL. Epithelial cells. Br Med Bull 1992;48: 85-96.
16. Derksen FJ, Robinson NE, Armstrong PJ, et al. Airway reactivity in ponies with recurrent airway obstruction (heaves). J Appl Physiol 1985;58:598-604.
17. Padrid P, Snook S, Finucane T, et al. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med 1995; 151:184-93.
18. Wegner CD, Gundel RG, Abraham WM, et al. The role of 5-lipoxygenase products in preclinical models of asthma. J Allergy Clin Immunol 1993;91:917-29.
19. Karol MH. Animal models of occupational asthma. Eur Respir J 1994;7:555-68.
20. Herz U, Lumpp U, Da Palma JC, et al. The relevance of murine animal models to study the development of allergic bronchial asthma. Immunol Cell Biol 1996;74:209-17.
21. Elwood W, Lotvall JO, Barnes PJ, et al. Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized Brown-Norway rats. J Allergy Clin Immunol 1991;88:951-60.
22. Nagai H, Yamaguchi S, Inagaki N, et al. Effect of anti-IL-5 monoclonal antibody on allergic responsiveness in mice. Life Sci 1993;53:PL243-7.
23. Foster PS, Hogan SP, Ramsay AJ, et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
24. Krinzman SJ, De Sanctis GT, Cernadas M, et al. T cell activation in a murine model of asthma. Am J Physiol 1996;271:L476-83.
25. Persson CGA, Erjefalt JS. "Ultimate activation" of eosinophils in vivo: lysis and release of clusters of free eosinophil granules. Thorax 1997;52:569-74.
26. Rossi GA, Szapiel S, Ferrans VJ, et al. Susceptibility to experimental interstitial lung disease is modified by immune and nonimmune related genes. Am Rev Respir Dis 1987;135:448-55.
27. Goding JW. Monoclonal antibodies: principles and practice. 2nd ed. New York: Academic Press, 1986.
28. Raabe OG, Al-Bayati MA, Teague SV, et al. Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Ann Occup Hyg 1988;32: S53-63.
29. Wilson MR, Easterbrook-Smith SB. Enzyme complex amplification: a signal amplification method for use in enzyme immunoassays. Anal Biochem 1993;209:183-7.
30. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
31. Kung TT, Jones H, Adams GK, et al. Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Appl Immunol 1994;105:83-90.
32. Brusselle GG, Kips JC, Tavernier JH, et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994;24:73-80.
33. Eum SY, Haile S, Lefort J, et al. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci USA 1995;92:12290-4.
34. Corry DB, Folkesson HG, Warnock ML, et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996;183:109-17.
35. Stafford S, Li H, Forsythe PA, et al. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J Immunol 1997;158:4953-60.
36. Ohkawara Y, Lei XF, Stampfli MR, et al. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 1997;16:510-20.
37. Korsgren M, Erjefalt JS, Korsgren O, et al. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997;185:885-92.
38. Kips JC, Cuvelier CA, Pauwels RA. Effect of acute and chronic antigen inhalation on airway morphology and responsiveness in actively sensitized rats. Am Rev Respir Dis 1992;145:1306-10.
39. Webber S, Battram C, Harman T, et al. Repeated aerosolised antigen challenge induces transient eosinophilia and chronic airway inflammation in the mouse. Am Rev Respir Dis 1994;149:A116.
40. Blyth DI, Pedrick MS, Savage TJ, et al. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am J Respir Cell Mol Biol 1996;14:425-38.
41. Holt PG, Batty JE, Turner KJ. Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 1981;42:409-17.
42. McMenamin C, Pimm C, McKersey M, et al. Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 1994;265:1869-71.
43. Renz H, Smith HR, Henson JE, et al. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol 1992;89:1127-38.
44. Mehlhop PD, van de Rijn M, Goldberg AB, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997;94:1344-9.
45. Hogan SP, Mould A, Kikutani H, et al. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 1997;99:1329-39.
46. Sterk PJ, Bel EH. Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J 1989;2:267-74.
47. Hessel EM, van Oosterhout AJM, Hofstra CL, et al. Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur J Pharmacol 1995;293:401-12.
48. Richards IM. Mouse models of allergic disease; how do they relate to asthma in man? Clin Exp Allergy 1996;26:618-20.
49. Hamelmann E, Schwarze J, Takeda K, et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156:766-75.
50. Sly PD, Hayden MJ, Petak F, et al. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med 1996;154:161-6.
51. Yung S, Durham SR, Corrigan CJ, et al. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995;12:477-87.
52. Humbert M, Corrigan CJ, Kimmitt P, et al. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997; 156:704-8.